|
Code
|
5237E
|
|
MA number
|
EU/1/20/1468/004
|
|
Product Form:
|
gra sac 28x75 mg/50 mg/100 mg (vre.BOPET/PE/fólia/PE)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU Orphan
|
|
MAH, country:
|
Vertex Pharmaceuticals (Ireland) Limited, Ireland
|
|
Therapeutic Class:
|
14 - BRONCHODILATANTIA, ANTIASTHMATICA
|
|
ATC:
|
| R |
RESPIRATORY SYSTEM |
| R07 |
OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07A |
OTHER RESPIRATORY SYSTEM PRODUCTS |
| R07AX |
Other respiratory system products |
| R07AX32 |
Ivacaftor,tezacaftor and elexacaftor |
|
|
Shelf life:
|
24 |
|
Route of admin.:
|
Oral use
|
European Medicines Agency's database
